Skip to main content

Table 1 Patient characteristics and PET information

From: The feasibility of [18F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study

Nr.

Age at diagnosis (years)

Weight (kg)

Histology

Stage

MTV (cm3)

Hypoxia in [18F]EF5 PET/CT

Hypoxic subvolume (cm3, % of MTV)

Injected [18F]EF5 activity (Mbq)

1

62

106

high grade serous

IIIC

571

yes

364 (64%)

381

2

56

81

endometrioid

IIB

250

yes

121 (49%)

367

3

65

100

sarcoma

IIB

1908

yes

42 (2%)

374

4

38

93

mucinous

IA

158

no

 

367

5

73

54

carcinosarcoma

IIIC

267

yes

17 (6%)

301

6

79

68

high grade serous

IVB

615

yes

202 (33%)

220

7

67

63

high grade serous

IIIC

955

no

 

385

8

56

70

fibroma

-

224

no

 

377

9

50

103

clear cell

IIIC

116

no

 

378

10

69

77

high grade serous

IVA

324

no

 

380

11

45

91

serous BOT

IA

66

no

 

374

12

65

69

high grade serous

IIIC

273

no

 

377

13

50

152

endometrioid

IIA

173

no

 

363

14

68

59

high grade serous

IIIC

1288

yes

87 (7%)

362

15

64

60

endometrioid

IIA

346

yes

33 (10%)

177

  1. BOT borderline ovarian tumor, MTV metabolic tumor volume, HSV hypoxic subvolume